These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23527598)

  • 1. Heparin-induced thrombocytopenia leading to stroke, lower extremity arterial occlusive disease, and skin necrosis: a case report.
    Nazliel B; Batur Caglayan HZ; Yildirim Capraz I; Irkec C; Yagci M; Gesoglu T
    Platelets; 2014; 25(2):129-31. PubMed ID: 23527598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-directed thrombolysis of acute lower extremity arterial thrombosis in a patient with heparin-induced thrombocytopenia.
    Turba UC; Bozlar U; Simsek S
    Catheter Cardiovasc Interv; 2007 Dec; 70(7):1046-50. PubMed ID: 18044775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebrovascular complications of immunologically mediated heparin-induced thrombocytopenia].
    Macha K; Kloska S; Dörfler A; Raaz-Schrauder D; Schwab S; Köhrmann M; Seifert F
    Fortschr Neurol Psychiatr; 2014 Mar; 82(3):149-54. PubMed ID: 24615586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin necroses, thrombocytopenia and deep venous thrombosis in subcutaneous thromboembolism prophylaxis with heparin: heparin-induced thrombocytopenia (HIT) type II].
    Stricker H; Mombelli G
    Ther Umsch; 1999 Sep; 56(9):484-6. PubMed ID: 10517114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
    Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
    Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation of heparin-induced thrombocytopenia.
    Warkentin TE
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):9-16; discussion 35-6. PubMed ID: 9855179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin-induced thrombocytopenia. Practical management of vascular complications].
    Obadia JF; Lancon JP; Becker F; David M; Etievent P
    Ann Chir; 1991; 45(8):729-34. PubMed ID: 1768034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
    Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
    Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia after liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
    Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower extremity manifestations and treatment of heparin-induced thrombocytopenia syndromes: a cohort study.
    Bibbo C; Hatfield PS
    J Foot Ankle Surg; 2011; 50(1):16-24. PubMed ID: 21055974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute aortic occlusion in a patient with heparin-induced thrombocytopenia treated by thrombectomy.
    Collins D; Moloney MA; O'Donnell D; Brophy D; Sheehan SJ
    Ir J Med Sci; 2012 Sep; 181(3):397-400. PubMed ID: 20665120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: clinical manifestations and management strategies.
    Menajovsky LB
    Am J Med; 2005 Aug; 118 Suppl 8A():21S-30S. PubMed ID: 16125511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute limb ischemia secondary to heparin-induced thrombocytopenia after cardiac surgery.
    Kreidy R; Hatem J
    J Med Liban; 2004; 52(3):175-81. PubMed ID: 16432978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia type II because of heparin-coated polytetrafluoroethylene graft used to bypass.
    Gabrielli R; Siani A; Rosati MS; Antonelli R; Accrocca F; Giordano GA; Marcucci G
    Ann Vasc Surg; 2011 Aug; 25(6):840.e9-12. PubMed ID: 21620669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: real-world issues.
    Linkins LA; Warkentin TE
    Semin Thromb Hemost; 2011 Sep; 37(6):653-63. PubMed ID: 22102268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
    Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
    Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
    Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic complications of heparin-induced thrombocytopenia.
    Giossi A; Del Zotto E; Volonghi I; Costa P; Bertuetti R; Remida P; Magoni M; Gasparotti R; Padovani A; Pezzini A
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):559-62. PubMed ID: 22688553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.